<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Cold Spring Harb Perspect Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Cold Spring Harb Perspect Med</journal-id>
<journal-id journal-id-type="publisher-id">cshperspectmed</journal-id>
<journal-id journal-id-type="hwp">cshperspectmed</journal-id>
<journal-title-group>
<journal-title>Cold Spring Harbor Perspectives in Medicine</journal-title>
</journal-title-group>
<issn pub-type="epub">2157-1422</issn>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26438606</article-id>
<article-id pub-id-type="pmc">4665035</article-id>
<article-id pub-id-type="doi">10.1101/cshperspect.a022731</article-id>
<article-id pub-id-type="publisher-id">a022731</article-id>
<article-categories>
<subj-group subj-group-type="hwp-journal-coll">
<subject>105</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Perspectives</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Epigenetics and Epilepsy</article-title>
<alt-title alt-title-type="left-running">D.C. Henshall and K. Kobow</alt-title>
<alt-title alt-title-type="right-running">Epigenetics and Epilepsy</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Henshall</surname>
<given-names>David C.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kobow</surname>
<given-names>Katja</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
</contrib-group>
<aff id="af1"><label>1</label>Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin 2, Ireland</aff>
<aff id="af2"><label>2</label>Department of Neuropathology, University Hospital Erlangen, 91054 Erlangen, Germany</aff>
<author-notes>
<corresp>
<italic>Correspondence:</italic>
<email>dhenshall@rcsi.ie</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>12</month>
<year>2015</year>
</pub-date>
<volume>5</volume>
<issue>12</issue>
<elocation-id>a022731</elocation-id>
<permissions>
<copyright-statement>Copyright Â© 2015 Cold Spring Harbor Laboratory Press; all rights reserved</copyright-statement>
<copyright-year>2015</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:href="cshperspectmed-BEP-a022731.pdf" xlink:type="simple"></self-uri>
<abstract>
<p>Epigenetic processes in the brain involve the transfer of information arising from short-lived cellular signals and changes in neuronal activity into lasting effects on gene expression. Key molecular mediators of epigenetics include methylation of DNA, histone modifications, and noncoding RNAs. Emerging findings in animal models and human brain tissue reveal that epilepsy and epileptogenesis are associated with changes to each of these contributors to the epigenome. Understanding and influencing the molecular mechanisms controlling epigenetic change could open new avenues for treatment. DNA methylation, particularly hypermethylation, has been found to increase within gene body regions and interference with DNA methylation in epilepsy can change gene expression profiles and influence epileptogenesis. Posttranscriptional modification of histones, including transient as well as sustained changes to phosphorylation and acetylation, have been reported, which appear to influence gene expression. Finally, roles have emerged for noncoding RNAs in brain excitability and seizure thresholds, including microRNA and long noncoding RNA. Together, research supports strong effects of epigenetics influencing gene expression in epilepsy, suggesting future therapeutic approaches to manipulate epigenetic processes to treat or prevent epilepsy.</p>
</abstract>
<abstract abstract-type="precis">
<p>Complex changes in epigenetic modifications and gene expression patterns are associated with epileptogenesis. Some changes confer beneficial adaptive changes that reduce brain excitability; others are pathogenic.</p>
</abstract>
<counts>
<page-count count="17"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>